CASI Pharmaceuticals Inc (NASDAQ:CASI) Stock is All Set To Gap-Up: But Why?

August 23, 2021

CASI Pharmaceuticals Inc (NASDAQ:CASI) up 35% in premarket after reporting Q2 2021 financial results in which the company realized $7.1 million in EVOMELA revenues. Analysts had predicted that the company would post a 130.3% YoY revenue increase to $6.15 million with a loss per share of $0.09 during the quarter. CEO Wei-Wu He stated that they are revising full-year 2021 revenue guidance based on the current trend, which is expected…


CASI Pharmaceuticals Inc (NASDAQ:CASI) Stock Moves Up Suddenly: A Bullish Sign?

August 16, 2021

The biopharmaceutical company CASI Pharmaceuticals Inc (NASDAQ: CASI) stock was on the radars of many investors this past Friday and ended the day with gains of as much as 13% amidst heavy action. The company, which is involved in the development of the development and commercialisation of novel pharmaceutical products and therapies, announced its financial results for the second fiscal quarter of 2021 on Thursday. In the second quarter that…


CASI Pharmaceuticals (NASDAQ:CASI) Stock Trends Lower: How to Trade Now?

August 13, 2021

Over the course of the past few weeks, the CASI Pharmaceuticals (NASDAQ:CASI) stock has had a pretty rough time and suffered from a selloff. In the past month, the stock has declined by as much as 13% and it is going to be interesting to see if the stock can actually make a recovery any time soon. Yesterday, the stock was in the news cycle after it announced its financial…